Yee Chung Cheng

1.1k total citations
39 papers, 745 citations indexed

About

Yee Chung Cheng is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yee Chung Cheng has authored 39 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 17 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yee Chung Cheng's work include Breast Cancer Treatment Studies (15 papers), Cancer Treatment and Pharmacology (7 papers) and HER2/EGFR in Cancer Research (7 papers). Yee Chung Cheng is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Cancer Treatment and Pharmacology (7 papers) and HER2/EGFR in Cancer Research (7 papers). Yee Chung Cheng collaborates with scholars based in United States, United Kingdom and Canada. Yee Chung Cheng's co-authors include Naoto T. Ueno, Gabriel N. Hortobágyi, Malcolm K. Brenner, Ingrid Kuehnle, M. Helen Huls, Hans‐Joachim Wagner, Adrian P. Gee, Richard E. Champlin, Helen E. Heslop and Cliona M. Rooney and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yee Chung Cheng

33 papers receiving 732 citations

Peers

Countries citing papers authored by Yee Chung Cheng

Since Specialization

Citations

This map shows the geographic impact of Yee Chung Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yee Chung Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yee Chung Cheng more than expected).

Fields of papers citing papers by Yee Chung Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yee Chung Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yee Chung Cheng. The network helps show where Yee Chung Cheng may publish in the future.

Co-authorship network of co-authors of Yee Chung Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yee Chung Cheng. A scholar is included among the top collaborators of Yee Chung Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yee Chung Cheng. Yee Chung Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inflammatory breast cancer, best practice in the community setting 2025 ·npj Breast Cancer ·Yōko Takahashi, (unknown), (unknown), (unknown), Jami Fukui, (unknown), Yee Chung Cheng, Naoto T. Ueno	0
2	Evaluation and management of incomplete ovarian function suppression in premenopausal breast cancer patients receiving anti-hormone therapy 2025 ·Breast Cancer Research ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Colin Mooney, (unknown), (unknown), Jutta Deininger, (unknown), (unknown), Sailaja Kamaraju, Lubna N. Chaudhary, Yee Chung Cheng	0
3	Team principles for successful interdisciplinary research teams 2023 ·SHILAP Revista de lepidopterología ·Sherry‐Ann Brown, Rodney Sparapani, Kristen Osinski, (unknown), (unknown), Feixiong Cheng, (unknown), (unknown), (unknown), Anai N. Kothari, Pedro J. Caraballo, Peter A. Noseworthy, Roger H. Johnson, (unknown), Louise Y. Sun, Bradley H. Crotty, Yee Chung Cheng, (unknown), (unknown), Jessica Olson	11
4	Abstract P6-05-34: Depression and Psychological Distress in Breast Cancer Patients 2023 ·Cancer Research ·(unknown), (unknown), Anikó Szabó, Yee Chung Cheng, Sailaja Kamaraju, Christopher R. Chitambar, (unknown), Lubna N. Chaudhary, (unknown)	0
5	Metaplastic Breast Cancer: Characteristics and Survival Outcomes 2022 ·Cureus ·Bicky Thapa, (unknown), (unknown), Xuefei Jia, Hamed Daw, Yee Chung Cheng, Mita Patel, (unknown), Abdo Haddad	14
6	Androgen receptor expression in patients with triple negative breast cancer treated with neoadjuvant chemotherapy: a single institution study 2022 ·Journal of Cancer ·(unknown), (unknown), (unknown), Lubna N. Chaudhary, Sailaja Kamaraju, (unknown), John A. Charlson, Christopher R. Chitambar, Julie M. Jorns, Yee Chung Cheng	6
7	Establishing an interdisciplinary research team for cardio-oncology artificial intelligence informatics precision and health equity 2022 ·SHILAP Revista de lepidopterología ·Sherry‐Ann Brown, Rodney Sparapani, Kristen Osinski, Jun Zhang, (unknown), Feixiong Cheng, (unknown), (unknown), (unknown), (unknown), (unknown), Anai N. Kothari, Pedro J. Caraballo, Peter A. Noseworthy, Roger H. Johnson, (unknown), Louise Y. Sun, Bradley H. Crotty, Yee Chung Cheng, Jessica Olson	20
8	Androgen receptor expression in patients with triple negative breast cancer treated with neoadjuvant chemotherapy: A single institution experience. 2018 ·Journal of Clinical Oncology ·(unknown), (unknown), Talha Badar, Alexis Visotcky, Lubna N. Chaudhary, Sailaja Kamaraju, (unknown), John A. Charlson, Christopher R. Chitambar, (unknown), Irene Aguilera‐Barrantes, Julie M. Jorns, Yee Chung Cheng	1
9	Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation 2017 ·Journal of Cancer ·Yee Chung Cheng, Yu‐Shu Shi, Mei-Jie Zhang, Ruta Brazauskas, Michael Hemmer, Michael Bishop, Yago Nieto, Edward A. Stadtmauer, Lois Ayash, Robert Peter Gale, Hillard Lazarus, L Holmberg, Michael Lill, Richard F. Olsson, Baldeep Wirk, Mukta Arora, Parameswaran Hari, Naoto T. Ueno	6
10	Paclitaxel and Trastuzumab as Maintenance Therapy in Patients with HER2-Positive Metastatic Breast Cancer Who Underwent High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation 2013 ·Journal of Cancer ·Yee Chung Cheng, Gabriela Rondón, Paolo Anderlini, Issa F. Khouri, Richard E. Champlin, Naoto T. Ueno	4
11	Phase II Study of Gonadotropin-Releasing Hormone Analog for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients 2012 ·The Oncologist ·Yee Chung Cheng, (unknown), Andrea Milbourne, Richard E. Champlin, Naoto T. Ueno	22
12	Improvement of survival and prospect of cure in patients with metastatic breast cancer 2011 ·Breast Cancer ·Yee Chung Cheng, Naoto T. Ueno	58
13	Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients 2010 ·British Journal of Cancer ·Yee Chung Cheng, Vicente Valero, M. Davis, (unknown), Ana M. González-Angulo, Richard L. Theriault, James L. Murray, Gabriel N. Hortobágyi, Naoto T. Ueno	6
14	Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer 2009 ·Bone Marrow Transplantation ·Jonas A. de Souza, M. Davis, Gabriela Rondón, Yee Chung Cheng, R B Jones, Richard E. Champlin, Naoto T. Ueno	7
15	Interleukin-2 and granulocyte–macrophage–colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer 2009 ·International Journal of Hematology ·Yee Chung Cheng, Gabriela Rondón, (unknown), John D. McMannis, Daniel R. Couriel, Marcos J. de Lima, Chitra Hosing, Issa F. Khouri, Sergio Giralt, Richard E. Champlin, Naoto T. Ueno	3
16	Long-term remission with imatinib mesylate in Philadelphia chromosome-positive AML presenting as primary extramedullary myeloid sarcoma 2008 ·Leukemia Research ·(unknown), Steven H. Kroft, Nancy B. Davis, David M. King, Yee Chung Cheng	6
17	Allogeneic hematopoietic cell transplantation for metastatic breast cancer 2007 ·Bone Marrow Transplantation ·Naoto T. Ueno, J. Douglas Rizzo, Taner Demirer, Yee Chung Cheng, Ute Hegenbart, M-J Zhang, Marco Bregni, Angelo Michele Carella, Didier Blaise, Asad Bashey, Jacob D. Bitran, Brian J. Bolwell, Gerald J. Elfenbein, (unknown), César O. Freytes, Robert Peter Gale, Hillard M. Lazarus, Richard E. Champlin, Patrick J. Stiff, Dietger Niederwieser	47
18	Natural History of Metastatic Renal Cell Carcinoma in Patients Who Underwent Consultation for Allogeneic Hematopoietic Stem Cell Transplantation 2007 ·Biology of Blood and Marrow Transplantation ·Kazutaka Nakayama, Nizar M. Tannir, Ping Liu, J. Kyle Wathen, Yee Chung Cheng, Richard E. Champlin, Naoto T. Ueno	4
19	The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy 2004 ·Biology of Blood and Marrow Transplantation ·Yee Chung Cheng, Gabriela Rondón, Ying Yang, Terry L. Smith, James Gajewski, Michèle L. Donato, Elizabeth J. Shpall, Roy B. Jones, Gabriel N. Hortobágyi, Richard E. Champlin, Naoto T. Ueno	14
20	Treatment of Relapsing Refractory Diffuse Large Cell Lymphoma After Matched Unrelated Donor Bone Marrow Transplant with Immunosuppression Withdrawal and Rituximab 2003 ·Leukemia & lymphoma ·Raymond Wong, Marcos de Lima, Daniel R. Couriel, Sergio Giralt, Chitra Hosing, Munir Shahjahan, Yee Chung Cheng, J Bruton, Richard Champlin, Issa F. Khouri	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact